How does Research Alliance Corp. Iv (NASDAQ: RACD) compare with companies in other sectors?

RACD on the NASDAQ trades at a P/E of N/A with a net margin of 0.00% and ROE of 0.00%, which positions it against peers in the Financial Services sector and beyond.

What are RACD's (NASDAQ) net and operating margins?

On the NASDAQ, RACD reports a net profit margin of 0.00% and an operating margin of 0.00%.

In what way does RACD's (NASDAQ) EPS trend reflect its financial momentum?

RACD's EPS growth on the NASDAQ is 0.00% and its 5-year EPS CAGR is 0.00%, indicating its earnings momentum.

What does RACD's (NASDAQ) ROE tell investors?

RACD on the NASDAQ posts an ROE of 0.00%, showing how much profit Research Alliance Corp. Iv generates for every $100 of shareholder equity.

How do I know if RACD (NASDAQ) is overvalued or undervalued?

RACD on the NASDAQ trades at a P/E of N/A and a PEG of N/A; compared with the P/E benchmark of 21.28, this suggests valuation should be reviewed against sector peers.

Research Alliance Corp. Iv Fundamental Analysis (NASDAQ: RACD)

RACD●NASDAQ

Financial ServicesFinancial - Conglomerates

$11.90

$0.10(0.85%)

U.S. Market opens in 44h 51m

Research Alliance Corp. Iv Fundamental Analysis (NASDAQ: RACD)

Research Alliance Corp. Iv (NASDAQ: RACD) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze RACD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze RACD's fundamental strength across five key dimensions:

Efficiency Score

Weak

RACD struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Weak

RACD trades at a premium to fair value.

PE < 25

N/A

PEG Ratio < 2

N/A

Growth Score

Weak

RACD faces weak or negative growth trends.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

RACD carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

RACD struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is RACD Expensive or Cheap?

No data available.

How Well Does RACD Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How RACD Stacks Against Its Sector Peers

Metric	RACD Value	Sector Average	Performance
P/E Ratio	N/A	21.28	N/A
ROE	N/A	667.00%	N/A
Net Margin	N/A	-489.00% (disorted)	N/A
Debt/Equity	N/A	0.80	N/A
Current Ratio	N/A	911.52	N/A
ROA	N/A	4469169.00%	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Research Alliance Corp. Iv's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

Research Alliance Corp. Iv Fundamental Analysis (NASDAQ: RACD)

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is RACD Expensive or Cheap?

How Well Does RACD Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How RACD Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

How does Research Alliance Corp. Iv (NASDAQ: RACD) compare with companies in other sectors?

What are RACD's (NASDAQ) net and operating margins?

In what way does RACD's (NASDAQ) EPS trend reflect its financial momentum?

What does RACD's (NASDAQ) ROE tell investors?

How do I know if RACD (NASDAQ) is overvalued or undervalued?